Leticia S. Do Amaral

Leticia S. Do Amaral

Auto-generated profile, based on publicly available information

Leticia S. Do Amaral

Department of Infectious Diseases University of Georgia, 120 Green Street, Athens, Georgia 30602, United States

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 October 2024 in ACS Infectious Diseases
Verified
Journal Article
Closed access
JMJopaul Mathew
Jopaul Mathew
BZBo Zhou
Bo Zhou
RHReagan S. Haney
Reagan S. Haney
KKKevin A. Kunz
Kevin A. Kunz
LALeticia S. Do Amaral
Leticia S. Do Amaral
PCPaul R. Carlier
Paul R. Carlier

14 January 2025 in ACS Infectious Diseases
Verified
Journal Article
Open access
EBEmily Bremers
Emily Bremers
JBJoshua H. Butler
Joshua H. Butler
LALeticia S. Do Amaral
Leticia S. Do Amaral
EMEmilio F. Merino
Emilio F. Merino
HAHanan Almolhim
Hanan Almolhim
MCMaria Belen Cassera
Maria Belen Cassera
Half the world's population is at risk of developing a malaria infection, which is caused by parasites of the genus Plasmodium. Currently, resistance has been identified to all clinically available antimalarials, highlighting an urgent need to develop novel compounds and better understand common mechanisms of resistance. We previously identified a novel tetrahydro-beta-carboline compound, PRC1590, which potently kills the malaria parasite. To better understand its mechanism of action, we selected for and characterized resistance to PRC1590 in Plasmodium falciparum. Through in vitro selection of resistance to PRC1590, we have identified that a single-nucleotide polymorphism on the parasite's multidrug resistance protein 1 (PfMDR1 G293V) mediates resistance to PRC1590. This mutation results in stereospecific resistance and sensitizes parasites to other antimalarials, such as mefloquine, quinine, and MMV019017. Intraerythrocytic asexual stage specificity assays have revealed that PRC1590 is most potent during the trophozoite stage when the parasite forms a single digestive vacuole (DV) and actively digests hemoglobin. Moreover, fluorescence microscopy revealed that PRC1590 disrupts the function of the DV, indicating a potential molecular target associated with this organelle. Our findings mark a significant step in understanding the mechanism of resistance and the mode of action of this emerging class of antimalarials. In addition, our results suggest a potential link between resistance mediated by PfMDR1 and PRC1590's molecular target. This research underscores the pressing need for future research aimed at investigating the intricate relationship between a compound's chemical scaffold, molecular target, and resistance mutations associated with PfMDR1.

27 April 2026 in Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
BZBo Zhou
Bo Zhou
LALeticia S. Do Amaral
Leticia S. Do Amaral
EBEmily Bremers
Emily Bremers
RHReagan S. Haney
Reagan S. Haney
LWLyric A. Wardlaw
Lyric A. Wardlaw
PCPaul R. Carlier
Paul R. Carlier